openPR Logo
Press release

Recombinant Hepatitis B Vaccine Market Will Exhibit an Impressive Expansion by 2024-2031

04-18-2024 03:50 PM CET | Health & Medicine

Press release from: Orion Market Research

Recombinant Hepatitis B Vaccine Market Will Exhibit

Recombinant hepatitis B vaccine market is expected to grow at a CAGR of 5.6% during the forecast. The rising incidence of acute and chronic hepatitis B infections across the globe is driving market growth. There is an increased demand for recombinant HBV vaccines 10mcg/ml and 10 mcg/0.5 ml, which provide long-lasting protection against chronic hepatitis B infection. The Hepatitis B vaccine is a preventative vaccine for hepatitis B. It's a shot that's administered to the arm or thigh. It works by causing the body to develop virus immunity.

To learn more about this report request a sample copy @

The increasing prevalence of chronic HBV infections, rising awareness about vaccination programs, and rising demand for preventive vaccines are some factors driving the global recombinant hepatitis B vaccine market. In addition, the vaccine manufacturers have been significantly focusing on the development of novel recombinant hepatitis B vaccines. North America is expected to hold a significant share in the market owing to the rising number of chronic HBV cases in the region. The Latin America recombinant hepatitis B vaccine market is driven by the rising focus on the prevention and treatment of HBV infection in the region. Further, owing to the rising incidence of HBV infections and growing awareness about vaccination programs in the region, Asia Pacific is expected to witness lucrative growth in the global recombinant hepatitis B vaccine market.

Global Recombinant Hepatitis B Vaccine Market Report by Segment

By Type

• 10mcg/ml
• 10mcg/0.5ml

By Application

• Newborn/Children
• Adult

A full report of Recombinant Hepatitis B Vaccine Market is available at:

Recombinant Hepatitis B Vaccine Market- Segment by Region

• United States
• Canada


• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe


• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Bharat Biotech International Ltd.
• CSL Ltd.
• Dynavax Technologies Corp
• Emergent BioSolutions Inc.
• GlaxoSmithKline PLC
• KM Biologics (Meiji Holdings Co., Ltd.)
• LG Chem Ltd.
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Serum Institute of India Pvt., Ltd.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

Media Contact:

Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Hepatitis B Vaccine Market Will Exhibit an Impressive Expansion by 2024-2031 here

News-ID: 3468931 • Views:

More Releases from Orion Market Research

US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecas …
The US geriatric medicine market is projected to grow at a CAGR of 4.6% during the forecast period. The US has high per capita income; access to advanced healthcare, a large elderly population, and a high prevalence of chronic diseases are some of the major factors driving the geriatric medicine market in the country. Moreover, a significant presence of key market players, such as Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global urometer market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period. The increasing cases of prostate cancer are expected to propel the growth of the global urometer market. Other than skin cancer, prostate cancer is the most common cancer in the US. According to the American Cancer Society (ACS), as of March 2022, around 268,490 new cases of prostate cancer and around
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global urethral dilators market is anticipated to grow at a considerable CAGR of 4.9% during the forecast. The growing incidence of Healthcare-Acquired Infections (HAI) is Boosting the Global Urethral Dilators Market. These are infections that patients get while receiving treatment for medical or surgical conditions. These infections can be occurred in hospitals, surgical centers, ambulatory clinics, and long-term care facilities such as nursing homes and rehabilitation facilities. To
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
The global transvaginal endoscopy market is anticipated to grow at a significant CAGR of 7.3% during the forecast period. Some of the prominent factors driving the market growth during the forecast period include the rising incidence of infertility among the female rising incidence of infertility globally, coupled with the increasing use of minimally invasive surgery. The MIS procedures involves minminal use of surgical incisions, and with the advent of laproscopic

All 5 Releases

More Releases for Recombinant

Global Recombinant Vaccines Market Segmentation, Business Analysis and Forecast …
Global Recombinant Vaccines Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Recombinant Vaccines Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms. This study provides
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
Human Recombinant Insulin Market Growth Analysis
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. The next
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have